Status:
COMPLETED
Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With Hypertension
Lead Sponsor:
Boryung Pharmaceutical Co., Ltd
Conditions:
Hypertension
Stroke
Eligibility:
All Genders
35-80 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the effect of cilnidipine (a calcium channel blocker) and losartan (an angiotensin II receptor blocker) on cerebral blood flow (CBF) and blood pressure in hyper...
Detailed Description
Design: Multi-center, randomized, double-blind, active control, titrated dose, non-inferiority trial Population Studied: We will prospectively recruit 250 hypertensive patients who had ischemic strok...
Eligibility Criteria
Inclusion
- Ischemic stroke patients with hypertension
Exclusion
- Cardioembolic stroke patients
- Severe hypertensive patients
- Secondary hypertensive patients
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT00325637
Start Date
January 1 2005
End Date
August 1 2007
Last Update
December 12 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Budang Hospital
Seongnam-si, Gyeonggi-do, South Korea